Colon
-
Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk
Phase 3 · randomised · 264 people · 1 site in France · Running, not taking new patients
-
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Phase 2 · randomised · 482 people · 14 sites in 5 countries · Recruiting now
-
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Phase 3 · randomised · 400 people · 366 sites in 25 countries · Recruiting now